Mucinex Childrens

Description

Mucinex® Children's MULTI-SYMPTOM COLD & SORE THROAT is a liquid formulation designed to address multiple cold symptoms. Each 4 FL OZ (118 mL) dose contains 325 mg of acetaminophen, serving as a pain reliever and fever reducer. The formulation also includes 10 mg of dextromethorphan HBr, which acts as a cough suppressant, and 200 mg of guaifenesin, an expectorant that aids in the clearance of mucus. Additionally, it contains 5 mg of phenylephrine HCl, a nasal decongestant that helps relieve nasal congestion. The product is presented in a very berry flavor.

Uses and Indications

This drug is indicated for the temporary relief of common cold and flu symptoms, including nasal congestion, stuffy nose, cough due to minor throat and bronchial irritation, intensity of coughing, and the impulse to cough, which may assist children in achieving sleep. It also alleviates minor aches and pains, sore throat, and headache. Additionally, this drug temporarily reduces fever and aids in loosening phlegm (mucus) and thinning bronchial secretions, facilitating the clearance of bothersome mucus and enhancing the productivity of coughs.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

This product is intended for use in children aged 6 years and older. The dosing instructions are as follows:

For children aged 6 to under 12 years, the recommended dose is 10 mL, administered using the dosing cup provided, every 4 hours as needed while symptoms persist. It is important not to exceed 5 doses within a 24-hour period.

For children under 6 years of age, the use of this product is not recommended.

Healthcare professionals should ensure that the dosing cup provided is used exclusively for this product and not with any other medications. It is critical to adhere to the specified dosing guidelines and to avoid exceeding the recommended dosage to prevent the risk of overdose.

Contraindications

The use of this product is contraindicated in the following situations:

• Co-administration with any other drug containing acetaminophen, whether prescription or nonprescription, due to the risk of acetaminophen overdose. Healthcare professionals should verify the presence of acetaminophen in other medications if there is uncertainty.

• In pediatric patients who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within 2 weeks of discontinuing such treatment. MAOIs are commonly prescribed for depression, psychiatric or emotional conditions, or Parkinson's disease. Consultation with a healthcare provider is advised if there is any doubt regarding the presence of an MAOI in the child's medication regimen.

• Exceeding the recommended dosage is contraindicated, as it may lead to overdose and associated complications.

Warnings and Precautions

This product contains acetaminophen, which poses a risk of severe liver damage if the child exceeds the maximum daily dosage of 5 doses within a 24-hour period or if it is taken concurrently with other medications containing acetaminophen. Healthcare professionals should be vigilant regarding the potential for severe skin reactions associated with acetaminophen use. Symptoms may include skin reddening, blisters, and rash. In the event of a skin reaction, it is imperative to discontinue use immediately and seek medical assistance.

In cases of severe sore throat that persists for more than 2 days or is accompanied by fever, headache, rash, nausea, or vomiting, prompt consultation with a physician is advised.

General precautions should be taken when considering this product for children with pre-existing medical conditions. Healthcare providers should inquire about the presence of liver disease, heart disease, high blood pressure, thyroid disease, diabetes, persistent or chronic cough (such as that associated with asthma), or cough accompanied by excessive phlegm (mucus). Additionally, it is essential to consult a doctor or pharmacist if the child is currently taking the anticoagulant warfarin.

In the event of an overdose, immediate medical attention is crucial. Healthcare professionals should instruct caregivers to contact a Poison Control Center or seek emergency medical help without delay, even if no signs or symptoms are immediately apparent.

Patients should be advised to discontinue use and consult a physician if they experience nervousness, dizziness, or sleeplessness. Further, if pain, nasal congestion, or cough worsens or persists beyond 5 days, or if fever intensifies or lasts more than 3 days, medical advice should be sought. Redness or swelling, the emergence of new symptoms, or a recurrence of cough accompanied by fever, rash, or headache that lasts should also prompt immediate medical evaluation, as these may indicate a serious underlying condition.

Side Effects

Severe liver damage may occur in patients taking this product, which contains acetaminophen, if they exceed five doses within a 24-hour period or if they use it concurrently with other medications containing acetaminophen.

Patients should be aware of the potential for severe skin reactions associated with acetaminophen. Symptoms may include skin reddening, blisters, and rash. In the event of a skin reaction, it is imperative to discontinue use and seek medical assistance immediately.

Patients are advised to stop use and consult a healthcare professional if they experience nervousness, dizziness, or sleeplessness. Additionally, if pain, nasal congestion, or cough worsens or persists beyond five days, or if fever worsens or lasts more than three days, medical advice should be sought. Redness or swelling, the emergence of new symptoms, or a cough that recurs or occurs alongside fever, rash, or headache that lasts may indicate a serious condition, warranting prompt medical evaluation.

An overdose warning is also pertinent; taking more than the recommended dose can lead to liver damage. In cases of suspected overdose, it is crucial to seek medical help or contact a Poison Control Center immediately, as timely medical intervention is essential, even if no signs or symptoms are initially apparent.

Drug Interactions

Concurrent use of this medication with any other drug containing acetaminophen, whether prescription or nonprescription, is contraindicated due to the risk of acetaminophen overdose and potential hepatotoxicity.

In pediatric patients, this medication should not be administered to children who are currently taking a prescription monoamine oxidase inhibitor (MAOI), which includes certain medications prescribed for depression, psychiatric disorders, or Parkinson's disease. Additionally, it is advised to avoid use for at least 2 weeks following the discontinuation of an MAOI to prevent serious interactions.

Healthcare professionals should be consulted prior to use if the child is concurrently taking warfarin, a blood-thinning medication. Monitoring of coagulation parameters may be warranted to ensure safety and efficacy in this context.

Packaging & NDC

Below are the non-prescription pack sizes of Mucinex Childrens (acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients aged 6 to under 12 years may be administered 10 mL using the dosing cup provided every 4 hours while symptoms persist, with a maximum of 5 doses in any 24-hour period. For children under 6 years of age, the use of this medication is not recommended.

Caution is advised due to the potential for severe liver damage if the maximum daily dosage of 5 doses is exceeded, particularly when combined with other medications containing acetaminophen. Prior to administration, it is essential to consult a healthcare professional if the child has a history of liver disease, heart disease, high blood pressure, thyroid disease, diabetes, or persistent cough associated with asthma or excessive phlegm. Additionally, consultation with a doctor or pharmacist is recommended if the child is concurrently taking the anticoagulant warfarin.

Geriatric Use

There is no specific information regarding the use of Mucinex Children's Multi-Symptom Cold and Sore Throat in geriatric patients. The prescribing information does not provide any recommended age considerations, dosage adjustments, safety concerns, or special precautions for elderly patients.

Healthcare providers should exercise caution when prescribing this medication to geriatric patients, as the absence of specific data necessitates careful monitoring and consideration of individual patient factors. It is advisable to assess the overall health status and potential comorbidities of elderly patients before initiating treatment.

Pregnancy

The safety of this product during pregnancy has not been established. Pregnant patients or those planning to become pregnant should consult a healthcare provider prior to use, as there may be potential risks to the fetus. Specific studies or data regarding fetal outcomes are not provided in the prescribing information.

No specific dosage modifications for pregnant individuals are mentioned; therefore, it is essential for healthcare providers to offer guidance tailored to the individual patient's circumstances. Special precautions are advised, and medical advice should be sought before using this product during pregnancy.

Lactation

There are no specific warnings or recommendations regarding nursing mothers or lactation in the provided text. Therefore, healthcare professionals should consider the absence of data when advising lactating mothers about the use of this medication. It is advisable to monitor breastfed infants for any potential effects, although no specific information is available.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the drug insert regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the absence of detailed guidance necessitates careful clinical judgment. Regular monitoring of renal function may be advisable in these patients to ensure safety and efficacy.

Hepatic Impairment

Patients with hepatic impairment should exercise caution when using this product, which contains acetaminophen. It is critical to adhere to the maximum daily limit of 5 doses within a 24-hour period, as exceeding this amount may lead to severe liver damage. Additionally, patients must avoid concurrent use of this product with other medications containing acetaminophen, as this combination significantly increases the risk of liver injury.

Before administering this product, it is advisable for caregivers to consult a healthcare professional if the child has a history of liver disease. In the event of an overdose, which may occur if the recommended dosage is exceeded, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended. Prompt medical attention is essential, even if no signs or symptoms of overdose are apparent. Monitoring liver function may be warranted in patients with compromised liver health to prevent potential adverse effects.

Overdosage

In the event of an overdose, defined as the ingestion of more than the recommended dose, there is a significant risk of liver damage. Healthcare professionals should be aware that the severity of the effects may not be immediately apparent, as symptoms can be delayed or absent initially.

It is imperative that individuals who suspect an overdose seek medical assistance without delay. Contacting a Poison Control Center or obtaining immediate medical help is crucial to ensure appropriate management and intervention. Quick medical attention is essential, even in the absence of noticeable signs or symptoms, to mitigate potential complications associated with liver damage.

Healthcare providers should remain vigilant and prepared to assess and manage any cases of overdose, emphasizing the importance of prompt action in these situations.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in question.

Postmarketing Experience

Reports of side effects have been received through voluntary submissions and surveillance programs. Healthcare professionals and patients are encouraged to report any adverse events to the designated contact number provided for this purpose.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion. It is important to inform patients not to use this product in conjunction with any other medications containing acetaminophen, whether prescription or nonprescription. If patients are uncertain whether a drug contains acetaminophen, they should be encouraged to consult a doctor or pharmacist.

Patients should be cautioned against using this medication in children who are currently taking a prescription monoamine oxidase inhibitor (MAOI) or within two weeks of stopping such a medication. If there is any uncertainty regarding the presence of an MAOI in a child's prescription, patients should seek guidance from a healthcare professional.

Patients should be instructed to discontinue use and consult a doctor if they experience nervousness, dizziness, or sleeplessness. Additionally, they should be advised to stop use and seek medical advice if pain, nasal congestion, or cough worsens or persists for more than five days, or if fever worsens or lasts more than three days. Redness or swelling, the emergence of new symptoms, or a cough that returns or occurs with fever, rash, or a headache that lasts should also prompt patients to contact a healthcare provider, as these may indicate a serious condition.

While using this product, patients must be reminded not to exceed the recommended dosage, and they should be made aware of the overdose warning. It is essential for patients to consult a doctor before use if the child has any of the following conditions: liver disease, heart disease, high blood pressure, thyroid disease, diabetes, or a persistent or chronic cough, such as that associated with asthma. Furthermore, patients should be advised to seek medical advice if the child has a cough accompanied by excessive phlegm (mucus) or if the child is taking the blood-thinning medication warfarin.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at a temperature range of 20-25°C (68-77°F). Refrigeration is not permitted, as it may compromise the integrity of the product. Proper handling and storage conditions must be adhered to in order to maintain the product's efficacy and safety.

Additional Clinical Information

The medication is administered orally, with specific dosing guidelines based on age. For children aged 6 to under 12 years, the recommended dose is 10 mL, taken every 4 hours as needed, not to exceed 5 doses within a 24-hour period. It is important to note that the medication is not recommended for children under 6 years of age.

No additional information is available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experiences.

Drug Information (PDF)

This file contains official product information for Mucinex Childrens, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)